GGrantIndex
Sort

15,842 grants matching “pancreatic cancer”

Dietary supplement use, physical activity, body mass index, and pancreatic cancer

$27
Ka He · Univ Of North Carolina Chapel Hill · R03 · FY2010 · CA

Oxidative stress-induced cellular servival pathways in pancreatic cancer

$18
Nathan Robert Wall · Loma Linda University · P20 · FY2008 · MD

Biostatistics and Bioinformatics Core

$2
Qi Long · University Of Pennsylvania · P30 · FY2021 · CA

N-3 Fatty Acid-Induced Akt Suppression: Chemoprevention for Pancreatic Neoplasia

$2
Paul Joseph Grippo · Northwestern University At Chicago · R01 · FY2014 · CA

Genomic Analysis Core

$2
Tapan Ganguly · University Of Pennsylvania · P30 · FY2021 · CA

Cancer Center Support Grant (CCSG)

$1
George J Weiner · University Of Iowa · P30 · FY2018 · CA

Wnt/?-catenin Signaling in Pancreatic Oncogenesis

$1
Anirban Maitra · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA

ROS-targeted therapy for pancreatic cancer

$1
Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2018 · CA

Alcohol-Induced End Organ Diseases Meetings

$1
Rebecca Leanne Smathers McCullough · University Of Colorado Denver · R13 · FY2025 · AA

TARGETING EXTRACELLULAR MATRIX-CANCER STEM CELL INTERACTIONS IN PANCREATIC CANCER

$1
William H Matsui · University Of Texas At Austin · R01 · FY2019 · CA

IGF binding protein-3 in beta cell apoptosis

$1
University Of California Los Angeles · K08 · FY2002 · DK

Molecular Oncogenic Properties of Mutant p53

$1
Xinbin Chen · University Of Alabama At Birmingham · R01 · FY2007 · CA

2017 and 2019 Alcohol-Induced End Organ Diseases Gordon Research Conference

$1
Laura E. Nagy · Gordon Research Conferences · U13 · FY2018 · AA

CELLULAR AND MOLECULAR MECHANISMS OF GASTROINTESTINAL CANCERS

$1
Lopa Mishra · University Of Tx Md Anderson Can Ctr · P01 · FY2011 · CA

Identifying Metabolic Vulnerabilities in Pancreatic Cancer

$1
Douglas Biancur · Whitehead Institute For Biomedical Res · K00 · FY2021 · CA

Chemical Probes to Study Methionine Redox Biology

$1
Christopher J. Chang · University Of California Berkeley · R01 · FY2024 · GM

Fully Quantitative Low-Dose, Motion-Resolved Dynamic Contrast-Enhanced MRI in Pancreatic Adenocarcinoma

$1
Anthony G Christodoulou · University Of California Los Angeles · R01 · FY2025 · EB

A novel glutaminase-free mammalian asparaginase with minimized immunogenicity to enable expanded use in cancer therapy

$1
Amanda M Schalk · Enzyme By Design, Inc. · R44 · FY2021 · CA

TGF-beta Signaling in Pancreatic Cancer

$1
Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2010 · CA

Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy

$1
Eric Collisson · Fred Hutchinson Cancer Center · R01 · FY2025 · CA

Reducing health disparities in foregut cancers by using modifiable barriers to predict risk for inequitable care: a novel implementation science-based approach

$1
Annabelle L Fonseca · University Of South Alabama · K23 · FY2023 · MD

N-3 Fatty Acid-Induced Akt Suppression: Chemoprevention for Pancreatic Neoplasia

$1
Paul Joseph Grippo · Northwestern University At Chicago · R01 · FY2014 · CA

Exosomal Contents Guided Amino Acids Treatment for Pancreatic Cancer

$1
Dali Sun · North Dakota State University · R21 · FY2023 · CA

Adoptive T Cell Therapy for Pancreatic Cancer

$1
Cassian Yee · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA

Anti-tumor potential of temperature-sensitive p53 mutants

$1
Jiandong Chen · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA